Despite the role of excitatory transmission to the nucleus accum-bens (NAc) in the actions of most drugs of abuse, the presence and functions of cannabinoid receptors (CB1) on the glutamater-gic cortical afferents to the NAc have never been explored. Here, immunohistochemistry has been used to show the localization of CB1 receptors on axonal terminals making contacts with the NAc GABAergic neurons. Electrophysiological techniques in the NAc slice preparation revealed that cannabimimetics [WIN 55,212,2 (WIN-2) and CP55940] strongly inhibit stimulus-evoked gluta-mate-mediated transmission. The inhibitory actions of WIN-2 were dose-dependent (EC50 of 293 6 13 nM) and reversed by the selective CB1 antagonist SR 141716A. In agreement with a pre-...
Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotrans...
The GPCRs CB1R and CB2R are targets for endocannabinoids, exogenous synthetic agents and phytocannab...
We examined the occurrence of functional interactions between CB1 cannabinoid and μ opioid receptors...
The nucleus accumbens (NAc) represents a critical site for the rewarding properties of diverse class...
Cannabinoids modulate inhibitory GABAergic neurotransmission in many brain regions. Within the tempo...
At present, little is known about the mechanisms by which cannabinoids exert their effects on the ce...
The endogenous cannabinoid system has been shown to play a crucial role in controlling neuronal exci...
The hypothesis of the present work was that activation of CB1 cannabinoid receptors inhibits GABAerg...
To date, it has been thought that cannabinoid receptors in CNS are primarily of the CB1R subtype, wi...
BACKGROUND: The bed nucleus of the stria terminalis (BNST) is involved in behaviors related to natur...
Type 1 cannabinoid receptors (CB1R) have a well established role in modulating GABAergic signalling ...
The effects of the cannabinoid receptor agonist WIN 55,212-2 on endogenous extracellular glutamate l...
In this study we investigated the effect of cannabinoids on [3H]glutamate release from hippocampal s...
AbstractWe investigated the effect of a synthetic cannabinoid, WIN 55,212-2 on excitatory postsynapt...
Cannabinoids have been shown to modulate central autonomic regulation and baroreflex control of bloo...
Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotrans...
The GPCRs CB1R and CB2R are targets for endocannabinoids, exogenous synthetic agents and phytocannab...
We examined the occurrence of functional interactions between CB1 cannabinoid and μ opioid receptors...
The nucleus accumbens (NAc) represents a critical site for the rewarding properties of diverse class...
Cannabinoids modulate inhibitory GABAergic neurotransmission in many brain regions. Within the tempo...
At present, little is known about the mechanisms by which cannabinoids exert their effects on the ce...
The endogenous cannabinoid system has been shown to play a crucial role in controlling neuronal exci...
The hypothesis of the present work was that activation of CB1 cannabinoid receptors inhibits GABAerg...
To date, it has been thought that cannabinoid receptors in CNS are primarily of the CB1R subtype, wi...
BACKGROUND: The bed nucleus of the stria terminalis (BNST) is involved in behaviors related to natur...
Type 1 cannabinoid receptors (CB1R) have a well established role in modulating GABAergic signalling ...
The effects of the cannabinoid receptor agonist WIN 55,212-2 on endogenous extracellular glutamate l...
In this study we investigated the effect of cannabinoids on [3H]glutamate release from hippocampal s...
AbstractWe investigated the effect of a synthetic cannabinoid, WIN 55,212-2 on excitatory postsynapt...
Cannabinoids have been shown to modulate central autonomic regulation and baroreflex control of bloo...
Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotrans...
The GPCRs CB1R and CB2R are targets for endocannabinoids, exogenous synthetic agents and phytocannab...
We examined the occurrence of functional interactions between CB1 cannabinoid and μ opioid receptors...